Position in ADMA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$30,183,959
-$14,915,422 QoQ
Shares Held
3,606,208
-28.0% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 323 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 88%
Shared 5%
None 7%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. ADMA ranks #48 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ADMA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,183,959 | 3,606,208 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $45,099,381 | 5,005,481 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $88,202,034 | 4,835,638 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $70,342,695 | 4,798,274 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $86,735,593 | 4,763,075 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $96,428,628 | 4,860,314 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $80,061,686 | 4,668,320 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $80,452,930 | 4,024,659 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $35,305,991 | 3,157,960 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $23,747,037 | 3,598,036 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $15,779,594 | 3,491,061 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $10,488,746 | 2,929,818 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,717,240 | 1,278,385 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $183,807 | 55,531 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $215,459 | 55,531 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $141,374 | 58,179 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $126,644 | 63,962 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $105,539 | 57,672 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $81,317 | 57,672 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $116,636 | 103,218 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $222,900 | 139,313 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $267,014 | 151,713 | Shares | Defined | 2021-05-14 | |
| 2020-09-30 | $28,297 | 11,840 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||